Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40000 participants
OBSERVATIONAL
2007-12-31
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Airways Dysfunction Following WTC Dust Exposure
NCT00395330
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)
NCT05215171
Health Effects of Repeated Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Volunteers
NCT05323240
Cardiopulmonary Effects of Particulate Exposure
NCT00011310
Biomarkers of Benzene Exposure in Inner City Residents
NCT00014963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* residents (children and adults) of Lower Manhattan communities at the time of the attacks, who remained or returned to their homes soon after the attacks
* individuals involved in debris removal in surrounding commercial and residential buildings,
* individuals involved in rescue, recovery and debris removal who have been previously screened through the World Trade Center Worker and Volunteer Medical Screening Program and are in need of continued treatment.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Occupational Safety and Health (NIOSH/CDC)
FED
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joan Reibman, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU School of Medicine/Bellevue Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Caplan-Shaw C, Kazeros A, Pradhan D, Berger K, Goldring R, Zhao S, Liu M, Shao Y, Fernandez-Beros ME, Marmor M, Levy-Carrick N, Rosen R, Ferri L, Reibman J. Improvement in severe lower respiratory symptoms and small airway function in World Trade Center dust exposed community members. Am J Ind Med. 2016 Sep;59(9):777-87. doi: 10.1002/ajim.22642.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-01
Identifier Type: -
Identifier Source: org_study_id
NCT01751711
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.